LPOXY Therapeutics is a clinical-stage biopharmaceutical company developing a novel non-antibiotic therapy to prevent Clostridioides difficile infections (Cdiff).
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 09/03/25 | $28,000,000 | Series A |
5Horizons Ventures | undisclosed |
